RSS-Feed abonnieren
DOI: 10.1055/s-2005-872411
Applications of Aminolevulinic Acid-Based Photodynamic Therapy in Cosmetic Facial Plastic Practices
Publikationsverlauf
Publikationsdatum:
28. Juli 2005 (online)
![](https://www.thieme-connect.de/media/fps/200502/lookinside/thumbnails/10.1055-s-2005-872411-1.jpg)
ABSTRACT
Photodynamic therapy (PDT) using aminolevulinic acid (ALA) is a promising new technique that is being studied extensively and used in a variety of cosmetic facial plastic arenas. These applications include U.S. Food and Drug Administration-approved treatment of premalignant and malignant skin conditions, as well as off-label uses for photorejuvenation, and the treatment of acne vulgaris, sebaceous gland hyperplasia, rosacea, and hirsutism. This article reviews the interplay of factors that contribute to the appearance of actinically damaged or photoaged skin, also known as dermatoheliosis. This is followed by a brief review of the mechanisms of action of ALA-based PDT and some of its cosmetic facial plastic uses.
KEYWORDS
Aminolevulinic acid - photodynamic therapy - photoaging - photorejuvenation - acne treatment
REFERENCES
- 1 Lavker R M, Zheng P, Doug G. Morphology of aged skin. Dermatol Clin. 1986; 4 379-389
- 2 Balin A K, Pratt L A. Physiological consequences of human skin aging. Cutis. 1989; 43 431-436
- 3 Pinnell S. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol. 2003; 48 1-19
- 4 Kligman A M. Early destructive effect of sunlight in human skin. JAMA. 1969; 210 2377-2380
- 5 Pearse A D, Marks R. Actinic keratoses and the epidermis on which they arise. Fr J Dermatol. 1977; 96 45-50
- 6 Gilchrest B A. A review of skin ageing and its medical therapy. Br J Dermatol. 1996; 135 867-875
- 7 Bhawan J, Andersen W, Lee J et al.. Photo-aging versus intrinsically aging: a morphologic assessment of facial skin. J Cutan Pathol. 1995; 22 154-159
- 8 Gilchrest B A, Murphy G, Soter N A. Effect of chronological aging and ultraviolet light on Langerhans cells in human epidermis. J Invest Dermatol. 1982; 79 85-88
- 9 Toyoda M, Bhawan J. Ultrastructural evidence for the participation of Langerhans cells in cutaneous photo-aging processes: a quantitative comparative study. J Dermatol Sci. 1997; 14 87-100
- 10 Montagna W, Kirchner S, Sarlisl K. Histology of sun-damaged skin. J Am Acad Dermatol. 1989; 21 907-918
- 11 Dermstadt G, Sidbury R. Hyperpigmented lesions. In: Behrman RE, Kliegman R, Jenson HB Nelson Textbook of Pediatrics, 16th ed. Philadelphia; Saunders 2000: 1983-1984
- 12 Uitto J, Fazio M J, Olsen D R. Molecular mechanisms of cutaneous aging: age- associated connective tissue alterations on the dermis. J Am Acad Dermatol. 1989; 21 614-622
- 13 Katzenberg A. The area of the dermal-epidermal junction in human skin. Anat Rec. 1958; 131 717-723
- 14 Smith J G, Davidson Jr E A, Sams W M, Clark Jr R D. Alterations in human dermal connective tissue with age and chronic sun damage. J Invest Dermatol. 1962; 39 347-350
- 15 Braverman I M, Fonferko E. Studies in cutaneous aging. I. The elastic fiber network. J Invest Dermatol. 1982; 78 434-443
- 16 Bernstein E F, Underhill C B, Hahn P J, Brown D B, Uitto J. Chronic sun exposure alters both the content and distribution of dermal glycosaminoglycans. Br J Dermatol. 1996; 135 255-262
- 17 Plewig G, Kligman A M. Proliferative activity of the sebaceous glands of the aged. J Invest Dermatol. 1978; 70 314-317
- 18 Luderschmidt C, Plewig G. Circumscribed sebaceous gland hyperplasia: autoradiographic and histoplanimetric studies. J Invest Dermatol. 1978; 70 207-209
- 19 Henderson B W, Dougherty T J. How does photodynamic therapy work?. Photochem Photobiol. 1992; 55 145-157
- 20 Dougherty T J, Gomer C J, Henderson B W et al.. Photodynamic therapy. J Natl Cancer Inst. 1998; 90 889-905
- 21 Kennedy J C, Pottier R H. Endogenous protophorphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992; 14 275-292
- 22 Kennedy J D, Pottier R H, Pross D C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990; 6 143-148
- 23 Peng Q, Warloe T, Berg K et al.. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997; 79 2282-2308
- 24 Van den Akker J THM, de Bruijn H S, Beijersbergen van Henegouwen G MJ, Star W M, Sterenborg H JCM. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer. Photochem Photobiol. 2000; 72 399-406
- 25 Wagnières G A, Star W M, Wilson B C. In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol. 1998; 68 603-632
- 26 af Klinteberg C, Enejder A M, Wang I, Andersson-Engels S, Svanberg S, Svanberg K. Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas. J Photochem Photobiol B. 1999; 49 120-128
- 27 Juzenas P, Sørensen R, Iani V, Moan J. Uptake of topically applied 5-aminolevulinic acid and production of protoporphyrin IX in normal mouse skin: dependence on skin temperature. Photochem Photobiol. 1999; 69 478-481
- 28 Morton C A, Mackie R M, Whitehurst C, Moore J V, McColl J H. Photodynamic therapy for basal cell carcinomas: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol. 1998; 134 248-249
- 29 Dierickx C C, Goldenhersh M, Dwyer P, Stratigos A, Mihm M, Anderson R R. Photodynamic therapy for nevus sebaceous with topical delta-aminolevulinic acid. Arch Dermatol. 1999; 135 637-640
- 30 Morton C A, Whitehurst C, Moseley H, McColl J H, Moore J V, MacKie R M. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol. 1996; 135 766-771
- 31 Morton C A, Whitehurst C, McColl J H et al.. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol. 2001; 137 319-324
- 32 Harth Y, Hirshowitz B, Kaplan B. Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia. Dermatol Surg. 1998; 24 723-726
- 33 Kurwa H A, Yong-Gee S A, Seed P T et al.. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol. 1999; 41(3 part 1) 414-418
- 34 Avram D K, Goldman M P. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol. 2004; 3(1 suppl) S36-S39
- 35 Bissonette R, Bergeron A, Liu Y. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond. J Drugs Dermatol. 2004; 3(1 suppl) S26-S31
- 36 Piacquadio D J, Chen D M, Farber H F et al.. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol. 2004; 140 41-46
- 37 Soler A M, Angell-Petersen E, Warloe T et al.. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylenediaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol. 2000; 71 724-729
- 38 Fink-Puches R, Soyer H P, Hofer A, Kerl H, Wolf P. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical aminolevulinic acid photodynamic therapy. Arch Dermatol. 1998; 134 821-826
- 39 Fink-Puches R, Wolf P, Kerl H. Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light. Arch Dermatol. 1997; 133 1494-1495
- 40 Hürlimann A F, Hänggi G, Panizzon R G. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion. Dermatology. 1998; 197 248-254
- 41 McCann D P, Spoor T C. Clinical effects of the 532nm diode laser for treating a variety of vascular and pigmented skin lesions. Cosmetic Dermatology. 2000; 13 25-28
- 42 Cassuto D A, Ancona D M, Emanuelli G. Treatment of facial telangiectasias with a diode-pumped Nd:YAG laser at 532 nm. J Cutan Laser Ther. 2000; 2 141-146
- 43 Hongcharu W, Taylor C R, Chang Y, Aghassi D, Suthamjariya K, Anderson R R. Topical ALA photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000; 115 183-192
- 44 Hongcharu W, Taylor C R, Chang Y et al.. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000; 115 183-189
- 45 Marjukka Suhonen T, Bouwstra J A, Urtti A. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release. 1999; 59 149-161
- 46 Van den Akker J THM, Iani V, Star W M, Sterenborg H JCM, Moan J. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: Differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. Photochem Photobiol. 2000; 72 681-689
Kristina ZakharyM.D. M.Sc. F.R.C.S.C.
University of Toronto, Department of Otolaryngology-Head and Neck Surgery UHN-TGH
190 Elizabeth Street, RFE 3S-438, Toronto
Ontario, Canada M5G-2N2